1. Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?

   • Alan Lyles

   Current Opinion 16 February 2017 Pages: 493 - 500

   

2. Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review

   • Melina Dritsaki
   • Felix Achana
   • Stavros Petrou

   Systematic Review 06 January 2017 Pages: 501 - 515

   

3. Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review

   • James Brockbank
   • Sorrel Wolowacz

   Systematic Review 10 February 2017 Pages: 517 - 535

   

4. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Christopher Carroll
   • Paul Tappenden
   • Anthony S. Wierzbicki

   Review Article 11 March 2017 Pages: 537 - 547

5. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland–Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data

   • Jason Madan
   • Kamran A. Khan
   • Sarah E. Lamb

   Original Research Article 06 January 2017 Pages: 549 - 559

   

6. Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study

   • Matthew Franklin
   • Sarah Davis
   • Steven Julious

   Original Research Article Open access 21 January 2017 Pages: 561 - 573

   

7. The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling

   • Asrul Akmal Shafie
   • Hui Yee Yeo
   • Amar-Singh HSS

   Original Research Article 15 February 2017 Pages: 575 - 589

   

8. Making Implicit Assumptions Explicit in the Costing of Informal Care: The Case of Head and Neck Cancer in Ireland

   • Paul Hanly
   • Rebecca Maguire
   • Linda Sharp

   Original Research Article 15 February 2017 Pages: 591 - 601

   

9. Comment on: “Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation”

   • Afschin Gandjour

   Letter to the Editor 21 March 2017 Pages: 603 - 604

10. Authors’ Reply to Gandjour: “Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation”

    • Monika Wagner
    • Mireille Goetghebeur

    Letter to the Editor 21 March 2017 Pages: 605 - 606